Clinical study of Phalatrikadi Vati in the Management of Pandu Roga in childrens.

Efficacy of Phalatrikadi Vati and Pandughni Vati in the Management of Pandu Roga w.s.r. to Iron Deficiency Anemia in Children - An Open Labelled Randomized Comparative Clinical Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/029681

Enrollment

Registered

2020-12-09

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D508- Other iron deficiency anemias

Interventions

Intervention1: Phalatrikadi Vati: Year (Vati-In three divided doses) For 2 years of age dose is 0.750 gm. For 3 years of age dose is 1.125 gm. For 4 years of age dose is 1.500 gm. For 5 years of ag

Eligibility

Inclusion criteria

Inclusion criteria: Children with Hb. 7 to 11 gm/dl. (WHO criteria) Children having classical Symptomatology of Panduroga / Iron Deficiency Anemia

Exclusion criteria

Exclusion criteria: Children age 16 years age of either sex Children with Haemoglobinopathies especially Thalassemia Children with conditions causing chronic blood loss like Worm infestation, Piles, Anal polyps, Haemophilia Children with congenital disorders and chronic debilitating diseases Children with Hb. Children with positive stool report of ova

Design outcomes

Primary

Measure	Time frame
EfficacyTimepoint: 4 months	—

Secondary

Measure	Time frame
Improve the health of childrensTimepoint: 4 months	—

Countries

India

Contacts

Public ContactDr V K Kori

IPGT and RA

drvkkori@yahoo.co.in9409207285

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026